3 Biotechs That Might Get Bought Out in 2023

3 Biotechs That Might Get Bought Out in 2023

Submitted by admin on April 26, 2023 - 5:41pm
Source: 
Motley Fool
News Tags: 
M&A
Madrigal Pharmaceuticals
Amylyx
Aurinia Pharmaceuticals
Headline: 
3 Biotechs That Might Get Bought Out in 2023
snippet: 

  • With multiple blockbuster drugs going off patent this decade, pharma companies are expected to ratchet up their M&A activities.
  • These three companies sport high-value assets that could attract suitors soon.

Do Not Allow Advertisers to Use My Personal information